Anna Aillerie
Head Of Commercial Operations, Biotechnology Business Unit
Gedeon Richter
Check out the incredible speaker line-up to see who will be joining Anna.
Download The Latest Agenda
Biosimilars Commercialisation Summit Agenda 2019
Conference Day One
Wednesday, February 5th, 2020
2:05 PM Case Study: Launching a Biosimilar into the European Marketplace in 2019
- Explore the current European market place by analysing the successes and failures of Big Pharma and SMEs in their approach to biosimilar commercialisation
- Benchmark your branding practice and commercial strategy against the challenges and opportunities encountered in the preparation for launch of a new biosimilar
- Get a sneak peek into pre-marketing and marketing activities around a launch of a new biosimilar into the European market
5:40 PM Panel Discussion: Boosting Patient Access to Biosimilars In Europe
- Explore the need for collaboration between Payers, Regulators and Industry to enhance patient access to biosimilars in Europe
- Consider how policy can be utilized as a tool to broaden patient access
- What does the future hold for the stability of the Biosimilars Market in the EU?